English
DIMA Biotechnology LLC is a leading biotech company providing cutting-edge preclinical research and development solutions for the BioPharma industry. The company offers a broad selection of pre-designed, validated antibody molecules specifically developed to support early-stage drug discovery. Its growing portfolio includes over 5,000 ready-to-use lead antibody molecules covering around 400 high-value drug targets. All molecules come with verified sequences and validation data to ensure research reliability. DIMA’s long-term goal is to provide lead antibodies for all potential drug targets—reinforcing its mission to accelerate antibody-based drug discovery for BioPharma partners through innovative solutions and flexible collaboration models.
Deutsch